67 related articles for article (PubMed ID: 38708180)
1. Surface Bio-engineered Polymeric Nanoparticles.
Haidar LL; Bilek M; Akhavan B
Small; 2024 May; 20(21):e2310876. PubMed ID: 38396265
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma Cancer Therapy.
Yang M; Chen W; Gupta D; Mei C; Yang Y; Zhao B; Qiu L; Chen J
Int J Nanomedicine; 2024; 19():3827-3846. PubMed ID: 38708180
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
4. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
Wang C; Wei X; Shao G
Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
[TBL] [Abstract][Full Text] [Related]
5. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
6. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
Du Z; Mao Y; Zhang P; Hu J; Fu J; You Q; Yin J
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35518-35532. PubMed ID: 34286569
[TBL] [Abstract][Full Text] [Related]
7. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
8. Techniques and status of hepatic arterial infusion chemotherapy for primary hepatobiliary cancers.
Zheng K; Wang X
Ther Adv Med Oncol; 2024; 16():17588359231225040. PubMed ID: 38282664
[TBL] [Abstract][Full Text] [Related]
9. Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer.
Zhou T; Wu J; Tang H; Liu D; Jeon BH; Jin W; Wang Y; Zheng Y; Khan A; Han H; Li X
NPJ Biofilms Microbiomes; 2024 Jan; 10(1):6. PubMed ID: 38245564
[TBL] [Abstract][Full Text] [Related]
10. Transarterial Radioembolization (TARE) in Patients with Hepatocellular Carcinoma: A Comparison of Palliative with Bridging-to-Transplant Concepts.
Schönherr J; Seifert P; Gühne F; Winkens T; Rauchfuß F; Settmacher U; Freesmeyer M; Drescher R
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201662
[TBL] [Abstract][Full Text] [Related]
11. Systemic Treatment in Intermediate Stage (Barcelona Clinic Liver Cancer-B) Hepatocellular Carcinoma.
Karagiannakis DS
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201479
[TBL] [Abstract][Full Text] [Related]
12. Exosome-derived miR-23a-5p inhibits HCC proliferation and angiogenesis by regulating PRDX2 expression: MiR-23a-5p/PRDX2 axis in HCC progression.
Zhao Y; Liu J; Xiong Z; Gu S; Xia X
Heliyon; 2024 Jan; 10(1):e23168. PubMed ID: 38187319
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors in gastrointestinal malignancies: an Umbrella review.
Noori M; Jafari-Raddani F; Davoodi-Moghaddam Z; Delshad M; Safiri S; Bashash D
Cancer Cell Int; 2024 Jan; 24(1):10. PubMed ID: 38183112
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
